chr9-130664780-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021619.3(PRDM12):āc.127A>Gā(p.Asn43Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000829 in 1,604,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N43S) has been classified as Uncertain significance.
Frequency
Consequence
NM_021619.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRDM12 | NM_021619.3 | c.127A>G | p.Asn43Asp | missense_variant | 1/5 | ENST00000253008.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRDM12 | ENST00000253008.3 | c.127A>G | p.Asn43Asp | missense_variant | 1/5 | 1 | NM_021619.3 | P1 | |
PRDM12 | ENST00000676323.1 | c.127A>G | p.Asn43Asp | missense_variant | 1/6 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000106 AC: 24AN: 225394Hom.: 0 AF XY: 0.000113 AC XY: 14AN XY: 123842
GnomAD4 exome AF: 0.0000757 AC: 110AN: 1452206Hom.: 0 Cov.: 34 AF XY: 0.0000831 AC XY: 60AN XY: 721800
GnomAD4 genome AF: 0.000151 AC: 23AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74332
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | PRDM12: PM2 - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Congenital insensitivity to pain-hypohidrosis syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 20, 2022 | This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 43 of the PRDM12 protein (p.Asn43Asp). This variant is present in population databases (rs149449772, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with PRDM12-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2023 | The c.127A>G (p.N43D) alteration is located in exon 1 (coding exon 1) of the PRDM12 gene. This alteration results from a A to G substitution at nucleotide position 127, causing the asparagine (N) at amino acid position 43 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at